<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="214602">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00292019</url>
  </required_header>
  <id_info>
    <org_study_id>R-04-030</org_study_id>
    <secondary_id>10280</secondary_id>
    <nct_id>NCT00292019</nct_id>
  </id_info>
  <brief_title>Robotic Laparoscopic Radical Prostatectomy</brief_title>
  <official_title>Robotic Laparoscopic Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to evaluate the role of RALRP in the management of localized prostate
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To establish a robotic-assisted laparoscopic radical prostatectomy programme at the
      University of Western Ontario/London Health Sciences Centre and to critically evaluate the
      role of this programme in the management of localized prostate cancer in surgical candidates
      Details of surgical procedure, operative outcome, patient outcome including quality of life
      will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2004</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Robotic prostatectomy</arm_group_label>
    <description>Patients who are eligible for a radical prostatectomy will have their surgery conducted with the aid of surgical robotics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic</intervention_name>
    <description>Patients with prostate cancer who are eligible for a radical prostatectomy will have their surgery conducted with the aid of surgical robots.</description>
    <arm_group_label>Robotic prostatectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Prostate cancer patients eligible for a radical prostatectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Informed Consent

          2. Locally confined, stage T1a, T2a or T2b prostate cancer

          3. Aged 40-65 and judged by the study doctor to be a suitable candidate for a radical
             prostatectomy.

          4. Serum prostate specific antigen equal to or less than 10mg/ml

          5. Histologically confirmed adenocarcinoma of the prostate

          6. Gleason score equal to or less than 7

          7. Life expectancy of greater than 10 years.

          8. Prostate size on TRUS measurement less than 40 grams

        Exclusion Criteria:

          1. Patients who have undergone prior hormone therapy.

          2. Patients with a previous transurethral resectioning of the prostate (TURP)

          3. History of other cancers other than basal cell carcinoma.

          4. Patients with any prior abdominal surgery.

          5. Any condition, or history of illness or surgery than, in the opinion of the
             investigator, might confound the results of the study or pose additional risk to the
             patient (eg significant cardiovascular conditions)

          6. Patients with a large median lobe of the prostate. -

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Chin, MD&lt; FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>London Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wendy Shoff, RN</last_name>
    <phone>519-685-8500</phone>
    <phone_ext>57350</phone_ext>
    <email>wendy.shoff@lhsc.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Chin, MD, fRCSC</last_name>
      <phone>519-685-8451</phone>
    </contact>
    <investigator>
      <last_name>Joseph Chin, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <lastchanged_date>July 7, 2009</lastchanged_date>
  <firstreceived_date>February 14, 2006</firstreceived_date>
  <responsible_party>
    <name_title>Dr. J. Chin</name_title>
    <organization>Lawson Health Research Institute</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
